Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON53120
NL-OMON53120
Recruiting
Not Applicable

Costimulatory and co-inhibitory molecules on tumor-infiltrating lymphocytes from hepatocellular carcinoma and cholangiocarcinoma - Costimulatory and co-inhibitory molecules in HCC and CCA

Erasmus MC, Universitair Medisch Centrum Rotterdam0 sites272 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Enrollment
272
Status
Recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Adult hepatocellular carcinoma (HCC) or cholangiocarcinoma (CCA) patients that
  • •will undergo surgery for this disease

Exclusion Criteria

  • •Patients who refuse blood donation/participation in the study
  • •Patients with a severe immunocompromised condition, or patients taking
  • •immunosuppressive medication

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Costimulatory and -inhibitory molecules on tumor-infiltrating lymphocytes from colorectal carcinoma and its metastasesbowel cancercolorectal carcinoma10017991
NL-OMON43140Stichting Leveronderzoek677
Recruiting
Not Applicable
Co-stimulatory and -inhibitory molecules on tumor-infiltrating lymphocytes from cholangiocarcinomabile duct cancercholangiocarcinoma10019815
NL-OMON43309Stichting Leveronderzoek102
Completed
Not Applicable
Investigation of correlation between antitumor effect of combined lapatinib/capecitabine therapy and p95HER2, PTEN and PIK3CA in patients with HER2 positive breast cancer
JPRN-UMIN000007153Kyushu Breast Cancer Study Group200
Completed
Phase 1
Chemotherapy in Treating Patients With Advanced Solid TumorsUnspecified Adult Solid Tumor, Protocol Specific
NCT00003721The University of Texas Health Science Center at San Antonio33
Active, not recruiting
Phase 1
A study of the use of apalutamide (ARN509) to reduce tumour volumes in men on active surveillance for prostate cancer
EUCTR2017-001700-29-GBCambridge University Hospitals NHS Foundation Trust & The University of Cambridge10